Immediate Impact
3 from Science/Nature 50 standout
Citing Papers
Drug resistance in ovarian cancer: from mechanism to clinical trial
2024 Standout
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
Works of H. Simon being referenced
823P Extended follow-up of a real-world cohort of patients (pts) with BRCA mutation (BRCAm) relapsed epithelial ovarian cancer (EOC) receiving olaparib maintenance therapy: The GINECO RETROLA study
2020
Prognostic factors of contralateral breast cancer (CBC) in 3,653 early breast cancer (EBC) patients (pts): 9-year follow-up results of French Adjuvant Study Group (FASG) trials
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| H. Simon | 85 | 135 | 124 | 47 | 316 | |
| Patrizio Capelli | 87 | 87 | 149 | 47 | 344 | |
| Görkem Aksu | 86 | 147 | 107 | 35 | 315 | |
| Ahsan Wahab | 125 | 54 | 75 | 57 | 353 | |
| M Giovannini | 129 | 108 | 81 | 35 | 323 | |
| Arne Koscielny | 53 | 73 | 204 | 33 | 347 | |
| Noman Paracha | 127 | 94 | 40 | 39 | 346 | |
| Ryo Miura | 93 | 54 | 136 | 52 | 353 | |
| Ali Kazemian | 131 | 119 | 75 | 41 | 294 | |
| Xiaofang Li | 33 | 58 | 87 | 31 | 302 | |
| Charles Giddings | 50 | 93 | 123 | 32 | 263 |
All Works
Loading papers...